Gotham Asset Management LLC boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 770,809 shares of the medical instruments supplier's stock after buying an additional 60,111 shares during the period. Gotham Asset Management LLC owned approximately 0.39% of DENTSPLY SIRONA worth $14,630,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of XRAY. Vanguard Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after acquiring an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after buying an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after buying an additional 314,343 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. UBS Group decreased their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Piper Sandler lowered their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $20.27.
View Our Latest Stock Analysis on XRAY
DENTSPLY SIRONA Price Performance
XRAY opened at $15.81 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $28.69. The company's 50 day simple moving average is $14.36 and its 200 day simple moving average is $17.58. The stock has a market capitalization of $3.15 billion, a PE ratio of -7.64, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the prior year, the firm posted $0.42 EPS. The business's revenue for the quarter was down 7.8% on a year-over-year basis. As a group, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.
DENTSPLY SIRONA Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.
Insiders Place Their Bets
In related news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is owned by insiders.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
